Point-of-care testing (POCT) refers to rapid diagnostic tests performed near the patient, providing immediate results without the need for centralized laboratories. These tests are widely used in detecting infectious diseases, monitoring chronic conditions, and managing emergency cases, allowing for quicker clinical decision-making. POCT devices include glucose monitors, rapid antigen tests, molecular assays, and portable blood analyzers. Their growing role in healthcare lies in improving accessibility, reducing turnaround times, and enhancing patient outcomes, especially in remote or resource-limited settings.
Market Analysis: In 2025, the global point-of-care testing market is valued at around USD 46.7 billion, fueled by demand for rapid diagnostics, infectious disease detection, and personalized healthcare. The market is projected to grow to USD 78.5 billion by 2030, at a CAGR of 11.0%. North America dominates due to strong adoption in hospitals and home care, while Asia-Pacific is the fastest-growing region, driven by increasing healthcare access and government-backed diagnostic programs. Technological advancements such as portable molecular testing and AI-enabled POCT devices are expected to further accelerate market growth.
